David Fuller

Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that cause inflammation in an effort to attract immune cells that would usually clear them. But for reasons that are not fully known, as we age, persistently senescent cells accumulate, leading to a vast number of age-related diseases. Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival.

OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.

Novi is simple security for renters and home owners without contracts and monthly fees and that eliminates false police alarms. Novi is designed to be discreet, user friendly, and affordable. Being a battery-powered DIY security system, it's a perfect security solution for renters and homeowners because it installs in 10 minutes with no holes or hardwires. The ceiling-mounted Novi Sensor is armed and disarmed through the user's smartphone app. When it detects either smoke or motion, it takes a series of pictures and sends those pictures to the user's smartphone. With picture in hand, the user can either call the police or ignore the alert if it's a false alarm. A unique element behind Novi is that the sensors communicate through a base station, which is connected to the internet. Having a base station allows for individuals to sync up multiple cameras in just one house. With multiple cameras, users can feel protected knowing that their house is being watched over. Novi's mission is to simplify home security. No contracts, no monthly fee, Novi.

Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that cause inflammation in an effort to attract immune cells that would usually clear them. But for reasons that are not fully known, as we age, persistently senescent cells accumulate, leading to a vast number of age-related diseases. Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival.

OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.

Secure your attack surface by aggregating and operationalizing your asset data. You’ve got assets? The rapid increase in digital transformation has created an overwhelming rise in cyber assets. JupiterOne connects the dots across your technology stack. We ingest asset data across your infrastructure, devices, users, IAM, cloud, policies, and more to create a single place for enterprise security teams to find information they need to triage risks and stay secure. We’ve got answers. JupiterOne helps you understand how your assets are connected, and gives you the information you need to make confident, data-driven decisions about risk and security. Armed with contextual knowledge about their cyber assets, CISOs from leading companies like Okta, Databricks, Hashicorp, and Robinhood all use JupiterOne to secure their attack surface.

LifeOmic, a healthcare technology company, works with health care providers, researchers, and health-focused enterprises to aggregate and utilize health data to improve patient outcomes and provide valuable, actionable insights. The LifeOmic Platform goes far beyond storage. Our secure, cloud-based platform forms the technology backbone for aggregating and managing complex health data in oncology, cardiology, MedTech, Pharma and more. The user-friendly interface, configurable mobile app, real-time analysis and visualization and attribute-based access controls meet the needs of each individual or organization. With the LifeOmic Platform you can: - Easily Collect & Analyze Data to Enable the Best Treatment Decision - Accelerate Speed to Market or Transition to Cloud with our Secure Platform - Deliver Precision Health at Scale & Engage Patients on our Configurable App